Brachytherapy Market Growth Accelerated by Increased Application of Brachytherapy for Cancer Treatment
Brachytherapy or internal radiation therapy is a type of
radiotherapy where a sealed radioactive source is placed inside or next to the
area requiring treatment. Brachytherapy offers advantages such as precise
delivery of radiation doses to cancerous tissues with minimal exposure to
surrounding healthy tissues. It is commonly used in treating cancers of
prostate, breast, cervix, and other internal organs. The global brachytherapy
market is estimated to be valued at US$ 972.21 Mn in 2023 and is expected to
exhibit a CAGR of 19% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
The increased application of brachytherapy for treating
cancerous tumors in tissues such as breast and prostate is expected to drive
the growth of brachytherapy market over the forecast period. Brachytherapy
offers several advantages over conventional external beam radiation therapy as
it allows delivery of higher and more concentrated doses of radiation to
cancerous tissues while limiting the radiation exposure to surrounding healthy
tissues. With the rising prevalence of cancer worldwide, brachytherapy is
gaining increased acceptance among patients and healthcare providers as an
effective treatment option with minimal side effects. The technological
advancements in brachytherapy such as high dose rate brachytherapy and 3D
imaging guided brachytherapy are further supporting the market growth.
Segment
Analysis
The global
brachytherapy market size is dominated by the breast cancer sub-segment.
This subsegment currently holds more than 24.21% market share due to high
prevalence of breast cancer worldwide. Brachytherapy is largely used treatment
for early stage breast cancer patients due to its highly focused, targeted and
localized dose delivery to the affected area with minimal damage to surrounding
tissues.
Key Takeaways
The global brachytherapy market is expected to witness high growth over the
forecast period.
Regional analysis: North America currently holds the largest
share of brachytherapy market owing to supportive reimbursement policies and
strong presence of key industry players in the region. Moreover, growing
adoption of novel technologies and awareness regarding cancer treatment options
contribute to market growth in the region. Asia Pacific is expected to exhibit
fastest growth rate over the forecast period on account of increasing cancer
burden, rising healthcare expenditure and growing medical tourism in the
region.
Key players operating in the brachytherapy market are Varian Medical Systems,
Elekta AB, Becton, Dickinson and Company, IsoRay, Inc., Eckert & Ziegler
BEBIG. Varian Medical Systems holds leading market position with wide portfolio
of brachytherapy solutions including GammaMed High Dose Rate (HDR) and Microselectron
HDR brachytherapy systems. Elekta AB offers brachytherapy solutions such as
GammaMed plus HDR and Flexitron afterloader systems.
Explore
Our More Blogs Here: https://www.newsstatix.com/brachytherapy-market-share-and-opportunity-analysis/
Comments
Post a Comment